Signal averaged electrocardiography and renal function in hypertensive patients
|
|
- Vivien Douglas
- 6 years ago
- Views:
Transcription
1 Signal averaged electrocardiography and renal function in hypertensive patients IOANA MOZOS 1, MIRCEA HANCU 1, LELIA SUSAN 2 1 Department of Functional Sciences 2 1 st Department of Internal Medicine Victor Babes University of Medicine and Pharmacy T. Vladimirescu Str. 14, Timisoara ROMANIA ioana_mozos@yahoo.com Abstract: - Abnormal signal averaged electrocardiograms (SAECGs) and late ventricular potentials (LVPs) are predictors of sudden cardiac death. The present study hypothesized that SAECGs are impaired in hypertensive patients with renal failure. A total of 30 patients with grade 2 hypertension underwent SAECG. Serum level of creatinine and glomerular filtration rate (GFR) were also assessed. At least one SAECG time-domain criteria was positive in 20 patients (67%) and 13 patients had at least two positive criteria (43%). Significant correlations and associations were obtained between SAECG criteria and creatinine and GFR, respectively. Impaired renal function was a sensitive and specific predictor of abnormal SAECGs and LVPs. An impaired renal function is significantly associated and predicts abnormal SAECGs and LVPs in hypertensive patients. Key-Words: - Signal averaged electrocardiography, late ventricular potentials, hypertension, renal function 1 Introduction Patients with chronic kidney disease are at a high risk of cardiovascular death [1,2]. Ventricular arrhythmias are related, in patients with end-stage renal failure, to hemodynamic status and fluctuations in electrolytes [3]. A high risk of sudden cardiac death was previously demonstrated in hypertensive patients, related to left ventricular hypertrophy, interstitial fibrosis, myocardial or subendocardial scars, silent myocardial ischemia, diastolic dysfunction and disturbances in cardiac autonomic balance [4]. Signal averaged electrocardiography (SAECG) is a non-invasive method, used to evaluate sudden cardiac death risk. Late ventricular potentials (LVPs) can be recorded as low amplitude, high frequency waves, appearing in the terminal part of the ECG QRS complex; they represent slowed conduction through a diseased myocardium and may form the substrate for life-threatening reentry ventricular arrhythmias [4].. 2 Problem Formulation The present study hypothesized that signal averaged electrocardiograms are impaired in hypertensive patients with renal failure. 2.1 Patients The most important inclusion criteria were hypertension, diagnosed considering the criteria of the European Society of Cardiology [5]. The most important exclusion criteria were: atrial flutter, electrolyte imbalances, active infections, peripheral edema and chronic obstructive pulmonary disease. The investigations conformed to the principles outlined in the Declaration of Helsinki (Cardiovascular Research 1997; 35:2-4) and were approved by the Ethics Committee of the University. A written informed consent was obtained from each patient Renal function Serum levels of creatinine were assessed in the entire study population. The glomerular filtration rate, the best index of kidney function, was calculated according to estimated glomerular filtration rate using the Modification of Diet in Renal Disease (MDRD) equation (GFRMD) [6], Cockroft Gault equation (GFRCG) [7] and Salazar-Corcoran equation for obese patients (GFRSC) [8] Signal averaged electrocardiography Each patient underwent signal averaged electrocardiography (SAECG). SAQRS (signal averaged ECG QRS duration), the duration of the ISBN:
2 low-amplitude signal (LAS40) and the root mean square of the terminal 40 ms of the filtered QRS (RMS40) were assessed [9]. The following timedomain criteria were positive: SAQRS >120 ms, LAS40 >38 ms and RMS40<20 µv [9]. SAECG was considered abnormal if at least one criteria was positive [10], and late ventricular potentials were present if at least two criteria were positive [11]. SAECG methodology was previously described [12] Standard 12-lead ECG was recorded using the same Siemens-Megacart electrocardiograph used to detect LVPs, at a paper speed of 25 mm/sec. Left ventricular hypertrophy (LVH) was diagnosed considering at least one of the following 6 ECG criteria: the Romhilt-Estes scoring system (a score of 5 diagnoses LVH and a score of 4 diagnoses probable LVH ) [13], the Sokolow-Lyon index (SV1/V2 + RV5/V6 >35 mm) [14], the Cornell voltage criteria (R in a VL + S in V3: >28 mm in men, >20 mm in women), the Cornell product (Cornell voltage x QRS duration>2436 mm.ms) [15, 16], the Mazzaro score ((highest R x deepest S) x QRS duration>2800 mm.ms) [17], the Gubner Ungerleider voltage (RI+SIII>25 mm) [18] Statistical analysis Continuous variables are presented as means ± SD (standard deviation). Linear and multiple regression analysis, Bravais-Pearson correlation coefficient (r), the t Student test, sensitivity and specificity were used as statistical methods. A p<0.05 was considered statistically significant. 3 Problem Solution 3.1. Characteristics of study population A total of 30 consecutive patients with grade 2 hypertension, aged 62±11 years, were enrolled in the study. The clinical characteristics of the patients are included in table 1. Serum creatinine was elevated >1.2 mg/dl in 7 patients (23%), GFRMD was <60 ml/min in 12 patients (40%) and 9 patients (30%) had low GFRCG and GFRSC (<60 ml/min), respectively Late ventricular potentials At least one time-domain criteria was positive in 20 patients (67%) (SAECG1) and 13 patients had at least two positive criteria (43%) (LVPs) Left ventricular hypertrophy was detected in 16 patients (53%) (table 1) Correlations According to the Bravais-Pearson correlation coefficient (r), significant correlations (p<0.05) were obtained between SAECG criteria and creatinine and GFR, respectively (table 2). The best correlations were obtained between LAS40 and GFRMD (r=-0.304) and GFRSC (r=-0.306), respectively Linear regression analysis Significant associations were found between SAECG s and serum creatinine and GFR, respectively (table 3). The most important association was: SAQRS - serum creatinine (multiple R = 0.847, R square = 0.709) Sensitivity and specificity Impaired renal function was a sensitive and specific predictor of abnormal SAECGs and LVPs (table 5-8). Table 1. Characteristics of the patients Clinical characteristics Age (mean±standard 62±11 years deviation) Gender 21(70%) male Cardiovascular risk 1-2 risk factors: 4 (13%) factors Three or more risk factors: 26 (87%) Dyslipidemia: 9 (30%) Obesity: 16(53%) Diabetes mellitus: 6 (20%) History of premature cardiovascular disease: 5 (17%) Associated pathology Coronary heart disease: 8 (27%) Congestive heart failure: 4 (13%) Peripheral artery disease: 1 (3%) Chronic hepatitis: 1 (3%) Liver cirrhosis: 1 (3%) Therapy Beta blockers: 14 (45%) Calcium-blockers: 9 (30%) Angiotensin converting enzyme inhibitors: 20 ISBN:
3 (65%) Angiotensin II receptor blockers: 4 (13%) Diuretics: 6 (20%) Nitrates: 8 (27%) SAQRS (ms) 109±21 LAS40 (ms) 44±21 RMS40 (microv) 21±12 Body mass index 30±4.67 (kg/m 2 ) Serum creatinine (mg/dl) 1.24±0.16 GFRMD (ml/min) 68±5.8 GFRCG (ml/min) 84±7.56 GFRSC (ml/min) 76±6 Left ventricular 16 (53%) hypertrophy Gubner-Ungerleider 21±4.63 voltage (mm) Sokolov-Lyon index 44±7.52 (mm) Cornell voltage index 23±4.81 (mm) Cornell product 1643±608 (mm.ms) Mazzaro score 2708±936 Romhilt-Estes score 3.1±1.4 SAECG = signal averaged electrocardiography QRS duration RMS40 = the root mean square of the terminal 40 ms of the filtered QRS GFR = glomerular filtration rate GFRMD = estimated glomerular filtration rate using GFRCG = GFR calculated using the Cockroft Gault equation GFRSC = GFR calculated using the Salazar- Corcoran equation Table 2. Correlations between signal averaged s and serum creatinine and glomerular filtration rate (GFR), respectively; r = Bravais Pearson correlation coefficient, p<0.05 SAQRS RMS40 LAS40 Serum r = r = r = creatinine GFRMD r = r = 0.06 r = GFRCG r = r = 0.08 r = GFRSC r = -0.2 r = 0.03 r = SAECG = signal averaged ECG QRS duration RMS40 = the root mean square of the terminal 40 ms of the filtered QRS GFRMD = estimated glomerular filtration rate using GFRCG = GFR calculated using the Cockroft Gault equation GFRSC = GFR calculated using the Salazar- Corcoran equation Table 3. Linear regression analysis SAQRScreatinine RMS40- creatinine LAS40- creatinine LAS40- GFRSC MR R 2 Adj. Signif. R 2 F < < < <0.01 SAECG = signal averaged ECG QRS duration RMS40 = the root mean square of the terminal 40 ms of the filtered QRS GFRSC = glomerular filtration rate calculated using the Salazar-Corcoran equation MR = multiple R = multiple correlation coefficient R 2 = R square = coefficient of determination Adj R 2 = adjusted R square = the coefficient of determination adjusted for the number of independent variables in the regression model Signif. F = significance of the association Table 4. Multiple regression analysis. Significance F<0.01. Parameter Assoc. MR R 2 Adj. GFRMD GFRCG SAQRS (p<0.01) LAS40 (p=0.007) SAQRS (p<0.01) LAS40 (p=0.015) R < <0.01 Assoc. = associated with MR = multiple R = multiple correlation coefficient R 2 = R square = coefficient of determination F ISBN:
4 Adj. R 2 = adjusted R square = the coefficient of determination adjusted for the number of independent variables in the regression model GFRMD = estimated glomerular filtration rate using GFRSC = GFR calculated using the Salazar- Corcoran equation SAECG = signal averaged ECG QRS duration Table 5. Elevated serum creatinine (>1.2 mg/dl) as predictor of abnormal signal averaged electrocardiography results (SAECG1) and late ventricular potentials (LVPs). SAECG1 sensitivity specificity LVPs sensitivity specificity The most sensitive predictor of SAECG1 and LVPs was the impaired estimated glomerular filtration rate calculated using the Modification of Diet in Renal Disease equation: GFRMD (sensitivity = 0.4 and 0.38, respectively) (table 6). Elevated serum creatinine was the most specific predictor of SAECG1 and LVPs (specificity = 0.8 and 0.7, respectively) (table 5). High specificity in predicting SAECG1 and LVPs was also obtained for GFR calculated using the Salazar-Corcoran equation: GFRSC (table 8). Table 6. Decreased estimated glomerular filtration rate using the Modification of Diet in Renal Disease equation (GFRMD) (<60 ml/min) as predictor of abnormal signal averaged electrocardiography results (SAECG1) and late ventricular potentials (LVPs). SAECG1 sensitivity specificity LVPs sensitivity specificity Table 7. Decreased glomerular filtration rate calculated using the Cockroft Gault equation (GFRCG) as predictor of abnormal signal averaged electrocardiography results (SAECG1) and late ventricular potentials (LVPs). SAECG1 sensitivity specificity LVPs sensitivity specificity Table 8. Decreased glomerular filtration rate calculated using the Salazar-Corcoran equation (GFRSC) as predictor of abnormal signal averaged electrocardiography results (SAECG1) and late ventricular potentials (LVPs). SAECG1 sensitivity specificity LVPs sensitivity specificity Left ventricular hypertrophy (LVH) was not a sensitive and specific predictor of abnormal signal averaged ECGs and late ventricular potentials, despite the high prevalence of SAECG abnormalities in patients with LVH (71%) (Table 9). Table 9. Left ventricular hypertrophy as predictor of abnormal signal averaged ECGs (SAECG1) and late ventricular potentials (LVPs) SAECG1 sensitivity specificity LVPs sensitivity specificity The t Student test found significantly higher glomerular filtration rates in patients without LVH compared to those with LVH (table 10) Discussions The main finding of the present study is the relation between an impaired renal function and late ISBN:
5 ventricular potentials and abnormal SAECGs in hypertensive patients. LVPs were found by several authors in hypertensive patients, related to eccentric left ventricular hypertrophy and disorganized ventricular activation, E/A ratios, dippers and nondippers [4]. Abnormalities of SAECG were also mentioned in patients with chronic renal failure and in patients undergoing hemodialysis and peritoneal dialysis [4]. Roithinger et al. did not find a significant association between mortality and LVPs or structural myocardial changes in hemodialysis patients [19]. Girgis et al. concluded that SAECG s improve with hemodialysis, and, decreased left ventricular dimensions, because of fluid removal [20]. The present study is the first attempt, as far as we know, to correlate SAECG s and renal function in hypertensive patients. Despite the high prevalence of SAECG abnormalities in patients with LVH, the later was not a sensitive or specific predictor for LVPs or abnormal SAECGs in the present study. The explanation could be renal failure, and, GFR was significantly higher in patients without LVH compared to those with LVH (table 10). Table 10. Estimated glomerular filtration rate using (GFRMD), glomerular filtration rate calculated using the Salazar-Corcoran equation (GFRSC) and GFR calculated using the Cockroft Gault equation (GFRCG) are significantly higher in patients without left ventricular hypertrophy (LVH) compared to those with LVH. overcome some of the limitations of creatinine measurements [22]. The prevalence of late ventricular potentials was higher in the present study (43%) compared to previous results: 24.5% [23], 25% [24] and 21.6% [25] in the studies of Vardas, Palatini and Galinier et al, respectively. The differences may be related to the characteristics of the study population. Associated pathology could have influenced SAECGs. Coronary heart disease was present only in 8 patients in the current study, and the prevalence of LVPs is low (7-10%) in patients with coronary heart disease without myocardial infarction [4]. Congestive heart failure was the associated pathology in 4 patients, and the results regarding the predictive value of late ventricular potentials for ventricular arrhythmias in heart failure patients are conflicting [4]. Therapy may have influenced LVPs, especially beta blockers [23] and angiotensin converting enzyme inhibitors [24]. The role of SAECG as a screening test is limited due to the low positive predictive accuracy. But, due to its high negative predictive value, LVPs can play an important role in selecting patients for interventional studies [4]. 4. Conclusion An impaired renal function is significantly associated and predicts abnormal signal averaged electrocardiograms and late ventricular potentials in hypertensive patients. LVH No LVH p GFRMD 52±23 68± GFRCG 65±31 76± GFRSC 72±36 80± No connection between LVPs and LVH in renal failure was previously mentioned [21] Study limitations An important limitation of the present study is the sample size. The results should be confirmed in larger groups and follow-up studies. Serum creatinine was considered an unreliable marker of GRF because it is affected by tubular secretion, age, gender, muscle mass, physical activity, and diet [22]. The Cockcroft-Gault, the Modification of Diet in Renal Disease (MDRD) and Salazar-Corcoran equations were used, because they Figure 1. Late ventricular potentials in a hypertensive patient. References: [1] X1. Polak-Jonkisz D, Laszki-Szczachor K, Purzyc L et al. Usefulness of body surface potential ISBN:
6 mapping for early identification of the intraventricular conduction disorders in young patients with chronic kidney disease. J Electrocardiol, 42, 2009, pp [2] X2. Hager CS, Jain S, Blackwell J et al. Effect of renal function on survival after implantable cardioverter defibrillator placement. Am J Cardiol, 106, 2010, pp [3] X3. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. JACC, 48(5), 2006, pp e247-e346. [4] X4. Breijo-Marquez FR. Cardiac arrhythmias- New Considerations, InTech, [5] X5. Mancia G, De Baker G, Dominiczak A, et al. Guidelines for the management of arterial hypertension. Eur Heart, 28, 2007, pp [6] X6. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 130, 1999, pp [7] X7. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 16(1), 1976, pp [8] X8. Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med, 84, 1988, pp [9] X9. Galinier M, Albenque JP, Afchar N, et al. Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J, 17, 1996, pp [10] X10. Armoundas AA, Rosenbaum DS, Ruskin JN et al. Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart, 80, 1998, pp [11] X11. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk and Council on Epidemiology and Prevention on Clinical Cardiology Committee on Electrocardiography and Arrhythmias. J Am Coll Cardiol, 52, 2008, pp [12] X12. Mozos I, Hancu M, Cristescu A. Ventricular arrhythmia risk in elderly heart failure patients. Review of Global Medicine and Healthcare Research, 1(1), 2010, pp [13] X13. Romhilt DW, Estes EHJr. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J, 75, 1968, pp [14] X14. Sokolov M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J, 37, 1949, pp [15] X15. Norman JE Jr, Levy D. Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy: the effects of hypertension and obesity. J Electrocardiol, 29(suppl), 1996, pp [16] X16. Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am. Coll. Cardiol, 6, 1985, pp [17] X17. Do Lago Mazzaro C, de Assis Costa F, Nogueira Bombig Manzoli MT, et al. Ventricular Mass and Electrocardiographic Criteria of Hypertrophy: Evaluation of New Score. Arq Bras Cardiol, 90(4), 2008, pp [18] X18. Gubner R, Ungerleider HE. Electrocardiographic criteria of left ventricular hypertrophy. Arch. Intern. Med, 72, 1943, pp [19] X19. Roithinger FX, Punzengruber C, Rossoll M, et al. Ventricular late potentials in haemodialysis patients and the risk of sudden death. Nephrol Dial Transplant, 7, 1992, pp [20] X20. Girgis I, Contreras G, Chakko S, et al. Effect of hemodialysis on the signal averaged electrocardiogram. Am J Kidney Dis, 34, 1999, pp [21] X21. Morales MA, Gremigini C, Dattalo P, et al. Signal-averaged ECG abnormalities in haemodialysis patients. Role of dialysis. Nephrol Dial Transplant, 13, 1998, pp [22] X22. Sahai M. Diseases of renal parenchyma, InTech, [23] X23. Vardas PE, Simandirakis EN, Parthenakis FI, et al. Study of late potentials and ventricular arrhythmias in hypertensive patients with normal electrocardiograms. Pacing Clin Electrophysiol, 17, 1994, pp [24] X24. Palatini P, Maraglino G, Accurso V, et al. Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate.br Heart J, 73, 1995, pp [25]. X25. Galinier M, Balanescu S, Fourcade J, et al. Prognostic value of arrhythmogenic markers in systemic hypertension. Eur Heart J, 18, 1997, pp ISBN:
Late ventricular potentials can be predicted from twelve-lead ECG in post-infarction heart failure
Late ventricular potentials can be predicted from twelve-lead ECG in post-infarction heart failure Ioana Mozos, Mircea Hancu, Corina Serban, Anca Tudor, Lelia Susan Vol. 3 No. 1 (January 2011) Special
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography
More informationMEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique
More informationUse of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia
October 1999 513 Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia G.M. KAMALOV, A.S. GALYAVICH, N.R. KHASSANOV,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationImpact of high-pass filtering on ECG quality and clinical interpretation: a comparison between 40 Hz and 150 Hz cutoff in an outpatient population
Impact of high-pass filtering on ECG quality and clinical interpretation: a comparison between 40 Hz and 150 Hz cutoff in an outpatient population Danilo Ricciardi, MD Cardiovascular Sciences Department
More informationClinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212
Clinical Policy: Reference Number: CP.MP.212 Effective Date: 03/05 Last Review Date: 09/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications
More informationSignal-Averaged Electrocardiography (SAECG)
Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are
More informationMEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More information4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.
The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid
More information20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1
Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney
More informationDr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.
Original Article In hypertensive patients measurement of left ventricular mass index by echocardiography and its correlation with current electrocardiographic criteria for the diagnosis of left ventricular
More information12 Lead ECG Workshop. Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA. California Association of Nurse Practitioners March 18, 2016
12 Lead ECG Workshop Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA California Association of Nurse Practitioners March 18, 2016 Learning Objectives Identify key changes on the ECG which
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More information03/17/16, 03/16/17, 03/15/18 CATEGORY: Technology Assessment. Proprietary Information of Excellus Health Plan, Inc.
MEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationArterial Age and Shift Work
340 Arterial Age and Shift Work Ioana Mozos 1*, Liliana Filimon 2 1 Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania 2 Department of Occupational
More informationOriginal Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
4 Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy Sirin Apiyasawat, Dujdao Sahasthas, Tachapong Ngarmukos, Pakorn Chandanamattha, Khanchit Likittanasombat
More informationDiastolic Function of the Left Ventricle Depending on the Degree of Renal Dysfunction in the Background of Treatment
American Journal of Medicine and Medical Sciences 2018, 8(9): 241-245 DOI: 10.5923/j.ajmms.20180809.05 Diastolic Function of the Left Ventricle Depending on the Degree of Renal Dysfunction in the Background
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationHIGH voltage of R waves in left precordial leads of the electrocardiogram
R-WAVE VOLTAGE CHANGES IN RELATION TO ARTERIAL PRESSURE IN HYPERTENSIVE PATIENTS ATHAN J. GEORGOPOULOS, M.D.,* PHILIP A. VLASTARIS, M.D.,f and WILLIAM L. PROUDFIT, M.D. Department of Cardiovascular Disease
More informationA Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome
A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A. Tolat A. Statement of study rationale and purpose T wave alternans (TWA), an alteration of the amplitude
More informationCME Article Brugada pattern masking anterior myocardial infarction
Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University
More informationAppendix D Output Code and Interpretation of Analysis
Appendix D Output Code and Interpretation of Analysis 8 Arrhythmia Code No. Description 8002 Marked rhythm irregularity 8110 Sinus rhythm 8102 Sinus arrhythmia 8108 Marked sinus arrhythmia 8120 Sinus tachycardia
More informationIntramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy
Case Report Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy Chin-Yu
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationDiploma in Electrocardiography
The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram
More informationGender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients
CLINICAL STUDY Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients Joji Ishikawa, 1 MD, Yuko Yamanaka, 2 MD, Ayumi Toba, 1 MD, Shintaro Watanabe, 3 MD and Kazumasa
More informationThe Immediate Reproducibility of T Wave Alternans During Bicycle Exercise
Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility
More informationPrevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study
International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120
More informationPresenter Disclosure Information
Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic
More informationPrognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension
JACC Vol. 31, No. 2 February 1998:383 90 383 Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension PAOLO VERDECCHIA, MD, GIUSEPPE
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationRegression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study Peter M. Okin, MD; Richard B. Devereux,
More informationECGs of structural heart disease: Part I
Electrocardiography Series Singapore Med J 2011; 52(12) 855 CME Article ECGs of structural heart disease: Part I Poh K K, Teo S G, Tay E L W, Yip J WL Cardiac Department, National University Heart Centre,
More informationPrediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring
Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationAssessment of Peguero Lo-Presti Criteria for Electrocardiographic. Diagnosis of LVH in Indian Subjects
Research Article Assessment of Peguero Lo-Presti Criteria for Electrocardiographic Diagnosis of LVH in Indian Subjects Suresh V Patted, Sanjay C Porwal*, Sameer S Ambar, M R Prasad, Akshay S Chincholi,
More informationPulse wave velocity, augmentation index and arterial age in students
Pulse wave velocity, augmentation index and arterial age in students IOANA MOZOS 1, SERBAN GLIGOR 2 1 Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara ROMANIA
More informationRenal Function Considerations for Stroke Prevention in Atrial Fibrillation
Renal Function Considerations for Stroke Prevention in Atrial Fibrillation Wednesday, March 28, 2018, 1:00PM ET Presenters: John Fanikos, RPh, MBA Curt Mahan, PharmD Paul Dobesh, PharmD, FCCP, BCPS Presenters
More informationfile://c:\documents and Settings\admin\My Documents\CV\92.htm
Page 1 of 5 Amir Farjam Fazelifar, M.D. Assistant Professor of Cardiac Electrophysiology Academic Address: Shaheed Rajaei Cardiovascular, Medical & Research Center, Vali- Asr Avenue Tehran- Iran Tel /
More informationBasic electrocardiography reading. R3 lee wei-chieh
Basic electrocardiography reading R3 lee wei-chieh The Normal Conduction System Lead Placement avf Limb Leads Precordial Leads Interpretation Rate Rhythm Interval Axis Chamber abnormality QRST change What
More informationSudden death as co-morbidity in patients following vascular intervention
Sudden death as co-morbidity in patients following vascular intervention Impact of ICD therapy Seah Nisam Director, Medical Science, Guidant Corporation Advanced Angioplasty Meeting (BCIS) London, 16 Jan,
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationOnline Appendix (JACC )
Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis
More informationCardiology. Objectives. Chapter
1:44 M age 1121 Chapter Cardiology Objectives art 1: Cardiovascular natomy and hysiology, ECG Monitoring, and Dysrhythmia nalysis (begins on p. 1127) fter reading art 1 of this chapter, you should be able
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview
ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview Nabil El-Sherif, MD SUNY - Downstate Medical Center & New York harbor VA Healthcare System Brooklyn, NY, USA Signal Averaged ECG: A Selective
More informationBiventricular Enlargement/ Hypertrophy
Biventricular Enlargement/ Hypertrophy Keywords congenital heart disease left ventricular hypertrophy right ventricular hypertrophy SR MITTAL Abstract Electrocardiographic diagnosis of early biventricular
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationAtrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA
Atrial fibrillation: a key determinant in the cardiovascular risk continuum u Prof. Joseph S. Alpert u Arizona, USA Disclosures u No major conflicts of interest: all honoraria
More informationClinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation
J Arrhythmia Vol 25 No 1 2009 Original Article Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation Seiji Takashio
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationSolutions for Every Day Problems Cardiologists and the ECG: Are We Really That Good at It? Part II Daniel José Piñeiro Profesor Titular de Medicina,
Solutions for Every Day Problems Cardiologists and the ECG: Are We Really That Good at It? Part II Daniel José Piñeiro Profesor Titular de Medicina, Universidad de Buenos Aires, Argentina Member, Membership
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationATHENA - A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular
1 ATHENA - A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patients
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationICD THERAPIES: are they harmful or just high risk markers?
ICD THERAPIES: are they harmful or just high risk markers? Konstantinos P. Letsas, MD, PhD, FESC LAB OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL ATHENS ICD therapies are common In a meta-analysis
More informationIt is occasionally problematic to differentiate ST-segment
CLINICAL INVESTIGATION Differential Diagnosis of Acute Pericarditis From Normal Variant Early Repolarization and Left Ventricular Hypertrophy With Early Repolarization: An Electrocardiographic Study Ravindra
More informationMy Patient Needs a Stress Test
My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction
More informationStudy of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri
Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.
More informationPlease check your answers with correct statements in answer pages after the ECG cases.
ECG Cases ECG Case 1 Springer International Publishing AG, part of Springer Nature 2018 S. Okutucu, A. Oto, Interpreting ECGs in Clinical Practice, In Clinical Practice, https://doi.org/10.1007/978-3-319-90557-0
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationCRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY FACULTY OF MEDICINE ABSTRACT DOCTORAL THESIS
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY FACULTY OF MEDICINE ABSTRACT DOCTORAL THESIS RISK FACTORS IN THE EMERGENCE OF POSTOPERATIVE RENAL FAILURE, IMPACT OF TREATMENT WITH ACE INHIBITORS Scientific
More informationT-Wave Alternans. Policy # Original Effective Date: 06/05/2002 Current Effective Date: 09/17/2014
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationMICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS
ECG MIMICS OF MYOCARDIAL ISCHEMIA AND INFARCTION 102.06.05 Tzong-Luen Wang MD, PhD, JM, FESC, FACC Professor. Medical School, Fu-Jen Catholic University Chief, Emergency Department, Shin-Kong Wu Ho-Su
More informationMedical Management of Acute Heart Failure
Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training
More informationSerum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease
Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationComorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes Yes Unknown
Comorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes HbA1c If medication; - Insulin - Oral antidiabetic - Both - Diet - treatment : Fasting blood sugar 7 mmol/l or post glucose 11.1 mmol/l and/or
More informationPrimary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life
Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge
More informationThe patient with electric storm
The complex patient in the cardiac care unit: The patient with electric storm Helmut U. Klein University of Rochester Medical Center Heart Research Follow-up Program and Isar Heart Center Muenchen Presenter
More informationPrognostic value of nonlinear heart rate dynamics in hemodialysis patients with coronary artery disease
Kidney International, Vol. 64 (2003), pp. 641 648 Prognostic value of nonlinear heart rate dynamics in hemodialysis patients with coronary artery disease HIDEKATSU FUKUTA, JUNICHIRO HAYANO, SHINJI ISHIHARA,
More informationMEDICINAL PRODUCTS FOR THE TREATMENT OF ARRHYTHMIAS
MEDICINAL PRODUCTS FOR THE TREATMENT OF ARRHYTHMIAS Guideline Title Medicinal Products for the Treatment of Arrhythmias Legislative basis Directive 75/318/EEC as amended Date of first adoption November
More informationElectrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III)
Journal of Rare Cardiovascular Diseases 2017; 3 (3): 81 85 www.jrcd.eu ORIGINAL PAPER Diseases of the heart Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III) Justyna
More informationClinical Policy: Holter Monitors Reference Number: CP.MP.113
Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of
More informationNon-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy
HOSPITAL CHRONICLES 2012, 7(3): 182 187 Case Report Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy Skevos Sideris, MD, Emmanouil Poulidakis, MD, Konstantinos
More informationEchocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationPause-induced Ventricular Tachycardia: Clinical Characteristics
Pause-induced Ventricular Tachycardia: Clinical Characteristics Margaret Bond A. Study Purpose and Rationale Until three decades ago, ventricular arrhythmias were thought to be rare in occurrence and their
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Clinical perspective It was recently discovered that small RNAs, called micrornas, circulate freely and stably in human plasma. This finding has sparked interest in the potential
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationLeft ventricular mass by 12-lead electrocardiogram in healthy subjects: comparison to cardiac magnetic resonance imaging.
Left ventricular mass by 12-lead electrocardiogram in healthy subjects: comparison to cardiac magnetic resonance imaging. Carlsson, Minna B; Trägårdh, Elin; Engblom, Henrik; Hedström, Erik; Wagner, Galen;
More informationThe estimation of kidney function with different formulas in overall population
137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different
More information402 Index. B β-blockers, 4, 5 Bradyarrhythmias, 76 77
Index A Acquired immunodeficiency syndrome (AIDS), 126, 163 Action potentials, 1, 5, 27 Acute coronary syndromes, 123t, 129 Adenosine, intravenous, 277 Alcohol abuse, as T wave inversion cause, 199 Aneurysm,
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationThe value of the coefficient of variation in assessing repeat variation in ECG measurements
European Heart Journal (1998) 19, 342 351 The value of the coefficient of variation in assessing repeat variation in ECG measurements S. C. McLaughlin*, T. C. Aitchison and P. W. Macfarlane* *Department
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationPrevention of Sudden Death in ARVC
ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationSummary of Research and Writing Activities In Cardiovascular Disease
Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts
More informationEXPERT CONSENSUS DOCUMENT
EXPERT CONSENSUS DOCUMENT American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients
More information